Simplex Trading’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Simplex Trading’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5	Closed	-$1K	–	8680
2019 Q4	$1K	Sell	5 -21	-81%	-$67	﹤0.01%	7174
2019 Q3	$7K	Buy	+26	New	+$73	﹤0.01%	6497
2019 Q2	–	Sell	-76	Closed	-$28K	–	8235
2019 Q1	$28K	Buy	76 +19	+33%	+$71	﹤0.01%	5479
2018 Q4	$20K	Buy	57 +5	+10%	+$22	﹤0.01%	5343
2018 Q3	$29K	Buy	52 +2	+4%	+$11	﹤0.01%	5688
2018 Q2	$25K	Buy	+50	New	+$257	﹤0.01%	5705
2017 Q4	–	Sell	-10	Closed	-$1K	–	7074
2017 Q3	$1K	Sell	10 -10	-50%	-$52	﹤0.01%	5687
2017 Q2	$2K	Buy	20 +8	+67%	+$36	﹤0.01%	5428
2017 Q1	$1K	Buy	+12	New	+$115	﹤0.01%	5940

Simplex Trading's FOMX Position: Q1 2020 in Review

Simplex Trading sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 38,420 shares — an estimated $127K sold.

Simplex Trading first reported a position in FOMX in Q1 2017 and held it in 10 quarters. The position peaked at $127K in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

Simplex Trading reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
Simplex Trading sold 38,420 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $127K.
Simplex Trading first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2017 and held it in 10 quarters.
Simplex Trading's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $127K in Q4 2019.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Simplex Trading's 13F filing for Q1 2020, filed 29 Apr 2020.